I am an expert in neurodegenerative disease research with a strong entrepreneurial background, comprehensive business education, and I am now eager to embark on a new transformative mission in the field of cell-and-gene therapy for Parkinson's disease, driven by an unwavering commitment and passion to make a meaningful impact in this area.